India remains main buyer of Russian Urals crude
- September 6, 2023
- Posted by: Quatro Strategies
- Categories: Europe, India, Oil & Gas, Sanctions & Regulation
India remained the primary buyer of Russian Urals oil loaded from state ports in August, despite a significant increase in prices for the grade. Traders and data from the London Stock Exchange Group (LSEG) confirmed India’s continued purchase of Russian Urals oil, even as the price differential between Urals and the dated Brent benchmark crude narrowed to a record low on a delivered ex-ship (DES) basis in Indian ports.
The narrowing price gap between Urals and Brent prompted Indian refineries to cut their purchases of Urals oil for September. The discounts for Urals oil loading in August fell to $5 per barrel and below on a DES basis in Indian ports, marking the lowest level since the European Union imposed an embargo on Russian oil.
This price increase for Urals was driven by Russia’s decision to reduce oil exports by 500,000 barrels per day (bpd) in August as part of its cooperation with OPEC+ to stabilize oil markets. Russia has committed to reducing oil exports by 300,000 bpd until the end of the year.
Russia’s significant reliance on India as its main oil buyer has raised concerns for Russian oil companies, especially as Russia prepares for increased loadings from Primorsk, Ust-Luga, and Novorossiysk ports in September, coinciding with decreased demand in India due to seasonal maintenance.
In August, Russian Urals oil deliveries to India accounted for about 69% of total shipments from these ports or approximately 74% of shipments of Russian-origin crude oil. This situation is in line with July, indicating India’s continued importance as a destination for Russian Urals oil.
Interested in learning more?
Sign up for Top Insights Today
Top Insights Today delivers the latest insights straight to your inbox.
You will get daily industry insights on
Oil & Gas, Rare Earths & Commodities, Mining & Metals, EVs & Battery Technology, ESG & Renewable Energy, AI & Semiconductors, Aerospace & Defense, Sanctions & Regulation, Business & Politics.
Read more insights
China’s factory PMI expected to show continued contraction in July
China’s factory activity is likely to have contracted for the third consecutive month in July. This persistent decline is fueling expectations that officials will need to introduce further economic stimulus measures. The protracted property crisis and job insecurity are significant drags on growth. The median forecast…
EU tells member states to brace for prolonged fuel squeeze
The European Union’s top energy official is warning member states to brace for a potentially extended period of energy market turmoil stemming from the ongoing military conflict in the Persian Gulf, signaling that Brussels views the current disruption not as a transient shock but as a structural challenge that could test the bloc’s supply resilience for months or longer.
In a letter addressed to national energy ministers ahead of an emergency coordination session scheduled for Tuesday, EU Energy Commissioner Dan Jorgensen urged governments to begin making concrete preparations for a scenario in which normal energy trade flows remain impaired well beyond the near term.
Singapore pushes for carve-outs from U.S. branded medicine tariffs
Singapore is scrambling for clarity after Washington’s latest trade move put a bullseye on branded medicines. Deputy Prime Minister Gan Kim Yong said local drugmakers are asking the U.S. whether their shipments can escape the newly announced tariffs if they already operate, or commit to expand, manufacturing inside the United States.
Singapore sells roughly S$4 billion (about US$3.1 billion) worth of pharmaceuticals to the American market each year, much of it originator brands, making the sector a critical pillar of the island’s export mix. The concern is immediate because President Donald Trump has unveiled duties of up to 100% on branded drugs, a measure explicitly designed to yank production onshore.